Brazil trial finds efficacy of Sinovac vaccine at 50.4 percent
Efficacy rate of China-developed product barely sufficient to secure regulatory approval.
External Content
| Source | RSS or Atom Feed |
| Feed Location | https://www.aljazeera.com/xml/rss/all.xml |
| Feed Title | Al Jazeera – Breaking News, World News and Video from Al Jazeera |
| Feed Link | https://www.aljazeera.com/ |
| Feed Copyright | © 2026 Al Jazeera Media Network |
| Reply | 0 comments |